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Abstract
Toll-like receptor 3 (TLR3) has been proposed to play a central role in the early recognition of viruses by sensing double
stranded RNA, a common intermediate of viral replication. However, several reports have demonstrated that TLR3 signaling
is either dispensable or even harmful following infection with certain viruses. Here, we asked whether TLR3 plays a role in
the response to coxsackievirus B4 (CB4), a prevalent human pathogen that has been associated with pancreatitis,
myocarditis and diabetes. We demonstrate that TLR3 signaling on macrophages is critical to establish protective immunity
to CB4. TLR3 deficient mice produced reduced pro-inflammatory mediators and are unable to control viral replication at the
early stages of infection resulting in severe cardiac damage. Intriguingly, the absence of TLR3 did not affect the activation of
several key innate and adaptive cellular effectors. This suggests that in the absence of TLR3 signaling on macrophages, viral
replication outpaces the developing adaptive immune response. We further demonstrate that the MyD88-dependent
signaling pathways are not only unable to compensate for the loss of TLR3, they are also dispensable in the response to this
RNA virus. Our results demonstrate that TLR3 is not simply part of a redundant system of viral recognition, but rather TLR3
plays an essential role in recognizing the molecular signatures associated with specific viruses including CB4.
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Introduction
Protective immunity to viral infection is often critically
dependent on early recognition of the pathogen. This first-line
of defense against viral infection is mediated, in part, by a series of
pattern-recognition receptors that include Toll-like receptors
(TLRs) and Rig-like helicases (RLH). TLRs act as sensors that
can recognize several molecular patterns associated with viruses
including surface glycoproteins (TLR1, 2 and 4) [1–3] and nucleic
acids (TLR3, 7, 8 and 9) [4–7]. Recognition of a cognate ligand
induces a downstream signaling cascade culminating in the release
of pro-inflammatory cytokines and maturation of antigen
presenting cells (APCs). As such, TLR signaling contributes to
the establishment of an anti-viral state and, by activating APCs, to
the establishment of an adaptive anti-viral response.
TLR3 has long been proposed to play an important role in the
innate response to viruses due to its capacity to recognize double
stranded (ds) RNA, a common intermediate of viral replication
[4]. Binding of dsRNA to TLR3 initiates a unique signaling
cascade that, unlike other TLR ligands (with the exception of some
TLR4 ligands that can initiate two separate signaling pathways)
does not depend on the signaling adaptor MyD88 but rather
utilizes the molecular adaptor TRIF (or TICAM-1) [8–10].
Despite the well documented capacity of Poly I:C, a synthetic
mimic of dsRNA, to increase antiviral immunity in a TLR3
dependent manner [11–16], the protective role of TLR3 in vivo
remains controversial. For instance, a protective role for TLR3 has
been demonstrated in a model of viral induced myocarditis.
Following encephalomyocarditis virus (EMCV) challenge, TLR3
deficiency resulted in heightened mortality that correlated with
increased viral replication and viral mediated cardiac damage.
However, in this study TLR3 signaling was only partially
protective as EMCV infection of wild-type (WT) mice still resulted
in over 75% mortality [17]. TLR3 was also shown to play a minor
role in the immune response to mouse cytomegalovirus (MCMV)
[18] and murine norovirus [19] as TLR3 deficient mice were
observed to harbor increased viral titers following infection
although this did not affect their capacity to survive viral infection.
In contrast, TLR9 deficient mice rapidly succumbed to infection
by MCMV [18]. Furthermore, a dominant negative TLR3 allele
was found in patients suffering from Herpes Simplex encephalitis
implying a role for this receptor in protection from neurotropic
viruses [20]. TLR3 signaling may be of particular importance for
the immune responses to viruses that do not directly infect
dendritic cells (DCs) as it was demonstrated to promote cross-
priming of CD8 T cells in response to dsRNA [21]. Conversely,
Edelmann and colleagues have reported that in the absence of
TLR3 signaling, mice can still mount a protective immune
response following challenge with various viruses, including
lymphocytic choriomeningitis virus (LCMV), vesicular stomatitis
virus (VSV), MCMV, and reovirus, resulting in unaffected viral
clearance and no increase in viral pathogenesis [22]. Further, it
was reported that TLR3 does not play a major role in the immune
response of astrocytes to Theiler’s murine encephalomyelitis virus
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deleterious role towards the host following pathogen challenge in
several models. TLR3 deficiency has been reported to confer a
survival advantage following influenza A challenge due to a
reduction in inflammation [24] and was also determined to protect
mice following challenge with lethal doses of Punta Toro Virus by
reducing viral-induced liver pathogenesis [25]. Furthermore,
TLR3 deficiency was shown to be beneficial following West Nile
virus infection. It was demonstrated that while the absence of
TLR3 signaling resulted in increased peripheral viral load it also
served to reduce neural inflammation leading to a decrease in both
viral loads and pathology in the brain [26]. Conversely, a recent
report has suggested that TLR3 may act to protect from West Nile
virus infection directly within neurons [27]. Taken together, these
data demonstrate that TLR3 may only be required for the
response to a specific subset of viruses. Further, multiple reports
suggest that TLR3 signaling is either dispensable or even harmful
following infection with other RNA viruses.
Coxsackievirus B4 (CB4) is a small, single stranded, positive
sense RNA picornavirus with tropism for the pancreas, where it
has been associated with induction of pancreatitis and autoim-
mune diabetes (reviewed in [28]), and the heart where it can cause
both acute and chronic myocarditis [29]. It is estimated that
coxsackieviral infections are responsible for nearly a third of all
new cases of dilated cardiomyopathy a disease responsible for the
majority of heart transplantations [26,30]. Additionally, CB4 was
originally isolated from a patient suffering from type 1 diabetes
[31] and has been demonstrated to accelerate onset of diabetes in
non-obese diabetic (NOD) mice [32,33]. The immune response to
this virus may be strongly dependent on innate mechanism as it
has been previously demonstrated that SCID mice are capable of
surviving infection even at high infectious doses [34]. It was
previously reported that CB4 can signal through TLR4 on
pancreatic islet cells [3] and that a closely related virus, CB3,
signals through TLR8 on cardiomyocytes [5]. The generation of
dsRNA, the ligand for TLR3, is a common by-product of the
replication cycle of single stranded RNA viruses including
picornaviruses like coxsackievirus and arenaviruses like LCMV.
The importance of TLRs and particularly TLR3 following CB4
infection in vivo remains to be elucidated.
Here, we demonstrate that the early immune response to CB4 is
solely dependent on TLR3 signaling as infection of TLR3 deficient
but not MyD88 deficient mice had fatal consequences. We have
further demonstrated that this increased mortality is due to the
inability of the host to control viral replication rapidly leading to
severe cardiac damage. Interestingly, TLR3 deficiency did not
affect the maturation of APCs or the activation of the adaptive
immune response. Rather, TLR3 deficiency decreases the
production of the pro-inflammatory mediators TNF-a and
CCL5 resulting in uncontrolled viral replication that outpaces
the developing adaptive immune response. Most importantly, we
demonstrate that adoptive transfer of WT macrophages is
sufficient to protect TLR3 deficient mice from succumbing to
CB4 infection indicating that TLR3 signaling on macrophages is
critical for the host response to this RNA virus.
Results
TLR3 plays a critical role for survival following CB4
infection
In order to elucidate the role of TLR3 in the innate immune
response to coxsackievirus, NOD mice deficient for TLR3
(TLR3KO) were infected with sublethal doses of CB4 and were
monitored for survival. As a control, NOD mice lacking MyD88
(MyD88KO) (and therefore unable to signal from the remaining
TLRs) were also infected with CB4. We observed a significant
increase in mortality following CB4 challenge in TLR3KO mice
with nearly 60% of TLR3KO mice dying by day 7 compared to
less than 15% of WT NOD and MyD88KO mice (Figure 1A). For
comparison to other studies and to ensure that the phenotype
observed was not simply dependent on mouse strain differences,
mice were challenged with LCMV as TLR3 was previously
demonstrated to be dispensable for the immune response to this
RNA virus [22]. As previously reported, deficiency of TLR3 did
not result in mortality following LCMV infection confirming that
TLR3 is not necessary for the response to this virus (Figure 1A)
[22]. Taken together, this suggests that while TLR3 plays a critical
role in the response to some RNA viruses like CB4, it is not
necessary for the control of other RNA viruses like LCMV.
Importantly, the MyD88-dependent TLR signaling pathway is not
Figure 1. Deficiency of TLR3 results in increased mortality and
increased viral replication following CB4 challenge. A) WT NOD
(solid grey line), TLR3KO (solid black line) and MyD88KO mice (dashed
black line) were challenged with 400 pfu of CB4 and mortality was
monitored. TLR3KO mice were also challenged with 1610
5 pfu of LCMV
(dashed grey line) as an additional control. Significantly decreased
survival was observed for TLR3KO mice challenged with CB4 compared
to all other mouse strains and treatment tested. B) Mice were sacrificed
at day 7 PI and viral load from the pancreas liver and heart of WT NOD
(black bars, n=8), TLR3KO (white bars, n=5) or MyD88KO (grey bars,
n=6) mice were measured by standard plaque assay. The viral titers are
presented as log10 pfu/g of tissue and represent the average values of
duplicates from at least 4 mice in each group. Stars denote statistical
significance.
doi:10.1371/journal.pone.0004127.g001
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compensate for the lack of TLR3 signaling.
Mortality is associated with increased viral replication
and increased cardiac damage
In order to determine whether increased mortality in TLR3
deficient mice resulted from an inability to control viral
replication, viral titers in the pancreas, liver and heart were
determined by plaque assay at day 3 and 7 post-infection (PI) with
CB4. No significant differences were observed at day 3 PI (data
not shown). Conversely, we observed a significant increase in viral
replication in the heart and liver of TLR3KO mice compared to
both WT NOD and MyD88KO mice at day 7 PI (Figure 1B). We
also observed increased viral replication in the pancreas of
TLR3KO mice although this difference did not reach statistical
significance (Figure 1B). Most notably, at day 7 PI the viral titers in
the hearts of TLR3KO mice were approximately 100 and 1000
fold higher than that observed in WT NOD and MyD88KO mice
respectively (Figure 1B). We next determined whether increased
viral replication resulted in heightened tissue damage that might
explain the rapid death observed in TLR3KO mice. Histological
examination of pancreatic tissue revealed extensive damage in
TLR3KO mice that was comparable to WT NOD mice
(Figure 2A). Additionally, blood glucose levels were comparable
in all 3 strains at day 3 and 7 PI (data not shown) suggesting that
pancreatic dysfunction is unlikely to explain the increased
mortality observed. Analysis of TLR3KO livers did not reveal
any obvious differences in pathology compared to either WT
NOD or MyD88KO mice following CB4 infection (Figure 2A).
Liver damage was further analyzed at day 3 and 7 PI using a
quantitative assay based on the levels of Alanine transaminase
(ALT) in the serum (Figure 2B). We observed increased ALT levels
in the serum of TLR3KO mice compared to WT NOD mice at
day 3 and 7 PI although this difference never reached statistical
significance suggesting that liver damage is not a major
contributor to the observed increased mortality in TLR3KO
mice. Finally, we measured the extent of cardiac damage.
Histological analysis revealed an atypical increase in the number
and severity of cardiac lesions at day 7 PI in TLR3KO mice
compared to both WT NOD and MyD88KO mice (Figure 2A).
These observations were confirmed by a significant increase in the
presence of cardiac Troponin I (cTn1), a marker for myocardial
injury [35], in the serum of TLR3KO mice compared to both WT
NOD and MyD88KO mice at day 7 PI (Figure 2C). Taken
together, these results demonstrate that the absence of signaling
from TLR3 but not other TLRs leads to uncontrolled viral
replication in several organs including the heart where heightened
damage is most likely responsible for the observed increase in
mortality.
TLR3 deficiency does not affect activation of innate or
adaptive effectors following CB4 infection
TLR mediated signals are important for the activation of several
innate effectors including NK cells and APCs. TLR signaling can
also affect the activation of the adaptive immune response either
directly or through effects on the APC population. As such, we
sought to determine the activation status of several important
antiviral effectors following CB4 infection in TLR3KO mice. First,
we determined the activation of NK (pan-NK
+ TCRb
2) and NK
T (pan-NK
+ and TCRb
+) cells by measuring surface expression of
the activation marker CD69 by flow cytometry. At 48 hours post-
infection, we observed that both NK and NKT cells from
TLR3KO mice upregulated CD69 to levels comparable with WT
NOD mice suggesting that these cells can respond normally to
viral infection despite the absence of TLR3 signaling (Figure 3A,
B). Interestingly, NK and NK T cell activation was completely
abrogated in MyD88KO mice (Figure S1A,B). This highlights an
important role for this pathway and other TLRs in the activation
of NK and NK T cells although it also suggests that activation of
these cells is not necessary for survival following CB4 challenge.
We next determined the activation status of APCs by measuring
surface expression of the costimulatory molecules CD80 (Figure 3)
and CD86 (data not shown) on macrophages (CD11b+CD11c2)
and DCs (CD11c+) at day 4 PI. We observed comparable
upregulation of costimulatory molecules on macrophages and DCs
in both WT NOD and TLR3KO mice demonstrating that TLR3
signaling is not necessary for the maturation of APCs and further
suggest that a defect in APC maturation is not responsible for the
increased mortality observed in TLR3KO mice (Figure 3C,D).
Following infection of MyD88KO mice, we observed reduced
maturation of both macrophages and DCs compared to WT mice
again suggesting a role for the MyD88 pathway in the maturation
of APCs (Figure S1C,D). These results suggest that the maturation
of APCs is not necessary for survival following CB4 infection. As a
control WT NOD and TLR3KO mice were also infected with
LCMV and as expected, no differences in APC maturation were
observed (Figure S2).
To determine whether TLR3 deficiency results in changes in
the activation of the adaptive immune system, the activation status
of B cells and T cells was monitored by flow cytometry. At day 4
PI we observed that B cells (CD19+) from TLR3KO mice
responded to viral infection by upregulating surface expression of
the activation marker CD69 and the costimulatory molecule
CD86 to levels comparable to that observed on B cells from WT
NOD mice (Figure S3). As for innate effectors, we observed
reduced activation of B cells in MyD88KO mice following CB4
challenge although as opposed to what we observed for NK cells,
activation was not completely abrogated (Figure S1E). Similarly,
the activation status of T cells from TLR3KO mice was
comparable to WT NOD mice at day 4 PI with either CB4
(Figure 4) or LCMV (Figure S4) as measured by upregulation of
CD69 and downregulation of CD62L and at day 7 (Figure S5) as
measured by upregulation of CD44. Consistent with the limited
maturation of APCs observed in MyD88KO mice following CB4
infection, T cell activation was also greatly reduced (Figure S1F,
G). This data suggests that the maturation and activation of both
innate and adaptive effectors following CB4 infection is dependent
on the MyD88 signaling pathway and independent of TLR3. This
further suggests that activation of cellular effectors is not critical for
survival following CB4 infection.
TLR3 deficiency results in lower production of
inflammatory mediators following infection
One important functional consequence of TLR ligation with a
cognate ligand is the production of pro-inflammatory cytokines
and chemokines. Accordingly, we determined the serum levels of
cytokines following infection. At 48 hours following infection we
measured the levels of IFNa in the serum of CB4 infected mice
(Figure S6), this production was abrogated in both TLR3KO and
MyD88KO mice suggesting that a deficiency in type 1 interferon
is unlikely to explain the increased mortality and viral replication
observed in TLR3KO mice. At day 4 following CB4 infection of
WT NOD mice, we observed significant increases compared to
uninfected controls in the levels of both TNF-a (Figure 5A) and
IL-6 (Figure 5B) and to a lesser extent IFN-c (Figure 5C) Little to
no production of IL-4, IL-5, IL-10, IL-12p70 was observed
following infection (data not shown). TLR3KO mice produced
CB4 Survival Requires TLR3
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and MyD88KO mice while the levels of all other cytokines
measured were similar to WT NOD mice (Figure 5). This suggests
that production of TNF-a following CB4 infection is strongly
dependent on TLR3 and independent of MyD88. Further, this
suggests that TNF-a production is critical to the early immune
response following infection. Interestingly, we observed a signif-
icantly reduced level of IL-6 and IFN-c following infection of
MyD88KO mice compared to WT NOD indicating that these
cytokines are produced following ligation of TLRs other than
TLR3 (Figure 5B,C). Further, these data suggest that IL-6 and
IFN-c do not play a critical role in the survival of mice following
CB4 challenge as MyD88KO mice survived infection and
controlled viral replication despite reduced levels of both of these
cytokines. Following LCMV infection and consistent with prior
data [36], we observed a strong cytokine response dominated by
the production of IFN-c (Figure 5C). It was previously reported
that cytokine production following LCMV infection is strongly
dependent on the MyD88 pathway [37,38]. Similarly, we
observed a significant reduction of IFN-c and TNF-a production
following infection of MyD88KO compared to WT NOD mice
(Figure 5A,B). TLR3KO mice produced comparable levels of
IFN-c following LCMV challenge (Figure 5C) confirming that this
receptor does not play a central role in the response to LCMV.
Figure 2. TLR3 deficiency results in increased cardiac damage during acute CB4 infection. A) Representative tissue section of pancreas
(left column), liver (center column) or heart (right column) stained for H&E from mock-infected (top row) or CB4-infected WT NOD (second row),
TLR3KO (third row) or MyD88KO (bottom row) mice at day 7 PI. B) Serum ALT levels of WT NOD (black bars), TLR3KO (white bars) or MyD88KO (grey
bars) mice either mock-infected with DMEM or at day 3 and 7 PI with CB4. Pooled data from at least 2 independent experiments are presented as
mean+/2s.e.m. C) Serum cardiac troponin 1 levels of WT NOD (black bars), TLR3KO (white bars) or MyD88KO (grey bars) mice either mock-infected
with DMEM or at day 3 and 7 PI with CB4. Pooled data from at least 2 independent experiments are presented as mean+/2s.e.m . Stars denote
statistical significance.
doi:10.1371/journal.pone.0004127.g002
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CB4 and LCMV. Following infection significant increases of
CCL2 (MCP-1), CCL3 (MIP-1a), CCL4 (MIP1-b), CCL5
(RANTES) and CXCL9 (MIG) were observed in WT NOD mice
compared to uninfected controls (Figure 6). Following CB4
challenge, TLR3KO mice produced similar levels of CCL2
(Figure 6A) and CXCL9 (Figure 6E) while levels of CCL3
(Figure 6B) and CCL4 (Figure 6C) were slightly reduced but were
not significantly different from either WT NOD controls or
MyD88KO mice suggesting that these chemokines are not critical
for survival following infection (Figure 6). Importantly, levels of
Figure 4. TLR3 deficiency does not affect the capacity of T cells
to activate following CB4 infection. Representative histograms of
CD62L and CD69 expression on the surface of (A) CD4 and (B) CD8 T
cells from WT NOD (left panels) and TLR3KO (right panels) mice at 4
days post-infection with 400 pfu of CB4 (solid black lines) or mock-
infection with DMEM (shaded histogram). Data is representative of at
least 2 separate experiments.
doi:10.1371/journal.pone.0004127.g004
Figure 3. TLR3 deficiency does not affect the capacity of innate
effectors to activate following CB4 infection. Representative
histograms of CD69 expression on (A) NK (Pan-NK
+, TCRb
2) or (B) NK T
cells (Pan-NK
+, TCRb
+) from WT NOD (left panels) and TLR3KO (right
panels) mice at 48 hours post-infection with 400 pfu of CB4 (solid black
lines) or mock-infection with DMEM (shaded histogram). Representative
histograms of CD80 expression on the surface of (C) macrophages
(CD11b+CD11c2) and (D) dendritic cells (CD11c+) from WT NOD (left
panels) and TLR3KO (right panels) mice at 4 days post-infection with
400 pfu of CB4 (solid black lines) or mock-infection with DMEM (shaded
histogram). Data is representative of at least 2 separate experiments.
doi:10.1371/journal.pone.0004127.g003
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both WT NOD and MyD88KO mice (Figure 6D) suggesting that
production of this chemokine following CB4 challenge is strongly
dependent on TLR3 and that production of this chemokine is
central to the capacity of the host to control CB4 viral replication.
No significant differences in chemokine production were observed
between WT NOD and MyD88KO mice following infection
further suggesting that the early immune response to CB4 is
MyD88 independent (Figure 6). As we observed in the case of the
cytokine response, the production of chemokines following LCMV
infection was primarily dependent on the MyD88 pathways with
MyD88KO mice producing significantly reduced levels of CCL2
and CCL5 compared to WT NOD mice. Taken together, these
data demonstrate that the production of some inflammatory
mediators following CB4 infection is independent of the MyD88
signaling pathway and strongly dependent on TLR3 signaling.
Further, the production of TNF-a and CCL5 appear to be critical
for the control of viral replication and the survival of the host
following CB4 challenge.
TLR3 signaling on macrophages plays an important role
in the immune response to CB4
Several cell types including macrophages and DCs are
responsible for production of cytokines and chemokines following
TLR ligation. In order to determine whether presence of TLR3 on
macrophages or DCs was sufficient to decrease the susceptibility of
a TLR3 deficient host, adoptive transfer experiments were
performed. Splenocytes from WT NOD or TLR3KO mice were
purified by flow cytometry in order to obtain two separate
populations based on CD11c and CD11b expression. TLR3KO
mice were adoptively transferred with a population containing
either predominantly macrophages (CD11b+CD11c2)o ra
population containing DCs (CD11c+) and challenged with CB4
at 24 hours post-transfer. We observed that while adoptive transfer
of WT DCs did not confer a survival advantage (data not shown),
transfer of WT macrophages resulted in greater survival with the
median survival time extended to 20 days compared to 9 days for
mock treated and nearly 25% more mice surviving to 21 days PI
(Figure 7A). Further, adoptive transfer of WT macrophages
conferred a significant survival advantage compared to mice
adoptively transferred with macrophages purified from TLR3KO
donors with the median survival time extended to 20 days
compared to 7.5 days and greater than 35% more mice surviving
to day 21 (Figure 7A) confirming that simply increasing the
number of macrophages available to respond to virus is not
sufficient to confer protection. Instead, TLR3 signaling on
macrophages is required to establish protection and ensure
survival following CB4 infection. In addition, this suggests that
TLR3 signaling on DCs is not sufficient to confer survival
following CB4 infection. Importantly, after transfer of WT
macrophages, we observed a significant reduction in serum levels
of cTn1 (Figure 7B) as well as the number and severity of cardiac
lesions in infected mice (Figure 7C) compared to infected mice
adoptively transferred with macrophages from TLR3KO mice.
This demonstrates that TLR3 signaling on macrophages is critical
to prevent viral-mediated cardiac pathology. Furthermore, we
observed that protection following adoptive transfer of WT
macrophages did not correlate with increased serum levels of
TNFa or CCL5 (data not shown). These results suggest that
macrophages contribute to protection independent of significant
increases of these mediators in the periphery and, as expected,
macrophages contribute to the antiviral response in a number of
ways both globally and locally within the infected tissue.
Discussion
In this study, we demonstrate that TLR3 signaling on
macrophages is required for survival following CB4 infection.
Mice lacking TLR3 succumb rapidly to viral infection due to
uncontrolled viral replication leading to a rapid increase in cardiac
damage. Conversely, we observed that MyD88 deficiency did not
result in increased mortality suggesting that signaling from other
Figure 5. TLR3 deficiency results in reduced production of TNF-
a following CB4 infection. Serum levels of A) TNF-a, B) IL-6 and C)
IFN-c from WT NOD (black bars), TLR3KO (white bars) and MyD88KO
(grey bars) mice were measured with a CBA inflammation kit 4 days
following infection with 400 pfu of CB4, 1610
5 pfu of LCMV or mock-
infection with DMEM. N= at least 3 for DMEM and LCMV treatments
and n= at least 5 mice for CB4 treatments. Pooled data from at least 2
independent experiments are presented as mean+/2s.e.m. Stars
denote statistical significance.
doi:10.1371/journal.pone.0004127.g005
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Our data further highlights the important role of pro-inflamma-
tory mediators, specifically TNF-a and CCL5, in controlling viral
replication in the host.
In light of the redundancy of innate receptors capable of
recognizing virus-associated patterns, it is intriguing that TLR3
plays such a critical in the early response to CB4 infection. Despite
the fact that coxsackieviruses have previously been described to
signal through other TLRs [3,5], our results suggests that the other
TLRs as well as the other innate viral sensors such as RLHs are
unable to compensate for the loss of TLR3. Additionally, our
results suggest that not only are other innate viral sensors unable to
compensate for the loss of TLR3, they are in fact dispensable for
the early response to CB4. This is supported by a report describing
that deficiency of MyD88 provided a survival advantage compared
to WT mice following challenge with high infectious doses of
coxsackievirus B3 [39]. These intriguing observations can be
explained by several non-exclusive mechanisms. One likely
explanation is that CB4 is recognized by TLRs other than
TLR3 but the functional consequences of this interaction are not
critical for survival. To this effect, we observed that IL-6
production was significantly reduced following CB4 infection in
Figure 6. TLR3 deficiency results in reduced production of CCL5 following CB4 infection. Serum levels of A) CCL2, B) CCL3, C) CCL4, D)
CCL5 and E) CXCL9 from WT NOD (black bars), TLR3KO (white bars) and MyD88KO (grey bars) mice were measured with a CBA chemokine flex set 4
days following infection with 400 pfu of CB4, 1610
5 pfu of LCMV or mock-infection with DMEM. n= at least 3 for DMEM and LCMV treatments and
n= at least 5 mice for CB4 treatments. Pooled data from at least 2 independent experiments are presented as mean+/2s.e.m. Stars denote statistical
significance.
doi:10.1371/journal.pone.0004127.g006
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signal through at least one MyD88-dependent pathway and that
the resulting production of IL-6 is not critical for the early control
of viral replication. Subcellular localization may explain why the
RLHs, in particular MDA-5 which has previously been demon-
strated to play an important role in the recognition of other viruses
including murine norovirus and the picornavirus, EMCV [19,40],
are unable to compensate for the lack of TLR3. As opposed to
TLR3 which is usually localized within endosomal compartments
[21], MDA-5 is localized in the cytoplasm [41]. CB4 enters the cell
by receptor-mediated endocytosis and therefore would be localized
within the endosome rapidly after infection. However, as CB4 is a
single stranded virus it seems unlikely that dsRNA intermediates
are generated prior to the start of viral replication in the
cytoplasm. Alternatively, other picornaviruses, including poliovirus
and hepatitis A virus, have been demonstrated to prevent MDA-5
signaling by cleaving either MDA-5 itself or the signaling adaptor
molecule mitochondrial antiviral signaling adaptor (MAVS)
[42,43]. Based on these reports, we are currently investigating
the interaction between RLHs and CB4 and speculate that this
virus may be able to abrogate signaling from RLHs potentially
explaining the critical role of TLR3 over the course of infection.
Here, we report that TLR3 deficiency does not affect the
activation of several cellular effectors typically involved in the
response to viruses including NK cells and APCs. Instead, the
absence of TLR3 signaling resulted in significantly reduced levels of
the cytokine TNF-a and the chemokine CCL5. This suggests that
early production of these inflammatory mediators plays a critical
role in controlling viral replication and that, in their absence, even
the activation of innate effectors and the adaptive response are
insufficient to reestablish control of the viral infection. To this effect,
we observed that although MyD88 mice present with reduced
immune cell activation following CB4 infection, they produce
similar levels of TNF-a and CCL5 compared to WT mice. The
survival of these mice following CB4 infection further highlights the
importance of these pro-inflammatory mediators in the control viral
replication at the earliest stages of infection. Similarly, it was
previouslyreportedthatSCID mice,thatlackTandB cells,areable
tosurvive the earlystagesofinfectionwithCB4suggestingthat these
cell types are not critical for survival [34].
TNF-a is a pro-inflammatory cytokine produced by several cell
types, including macrophages, that has been ascribed antiviral
properties both in vitro and in vivo (reviewed in [44]). Wada and
colleagues have reported that mice lacking TNF-a succumb
Figure 7. Adoptive transfer of WT macrophages rescues TLR3KO mice following CB4 challenge. A) TLR3KO mice were adoptively
transferred with macrophages from WT NOD mice (dashed black line) or macrophages from TLR3KO mice (solid grey line) or mock-treated with
DMEM (solid black line) and infected with 400 pfu of CB4 24 hours post-transfer. B) Serum cardiac troponin 1 levels of TLR3KO mice adoptively
transferred with either WT NOD macrophages (black bars, n=5) or TLR3KO macrophages (white bars, n=3) at day 7 PI with CB4. Pooled data from at
least 2 independent experiments are presented as mean+/2s.e.m. Stars denote statistical significance. C) Representative tissue section of day 7 PI
hearts stained for H&E from CB4-infected TL3KO mice adoptively transferred with WT NOD macrophages (left panel) or TLR3KO macrophages (right
panel).
doi:10.1371/journal.pone.0004127.g007
CB4 Survival Requires TLR3
PLoS ONE | www.plosone.org 8 January 2009 | Volume 4 | Issue 1 | e4127rapidly to EMCV infection due to increased viral replication in the
heart [45], an observation that was supported following EMCV
infection of TLR3 deficient mice where reduced TNF-a
production was observed and correlated with increased viral
replication, cardiac damage and increased mortality [17]. The
antiviral effects of TNF-a may be, in part, mediated by its capacity
to induce the production of nitric oxide from macrophages as this
molecule has previously been demonstrated to play an important
role in the control of coxsackieviral replication within the heart
[46]. Taken together with the data presented in this report, this
suggests that the TLR3-dependent production TNF-a plays a
particularly important role in cardiac protection following
infection with cardiotropic viruses.
CCL5 is a pro-inflammatory chemokine with chemotactic
properties towards both T cells and monocytes/macrophages that
is commonly associated with anti-viral responses. Blocking CCL5
activity has previously been demonstrated to result in increased
viral antigen in the central nervous system (CNS) of mice following
TMEV challenge [47]. Interestingly, normal T cell infiltration was
also observed in these mice suggesting that T cells were still able to
migrate to the CNS and that the antiviral activity of CCL5 is not
simply due to recruitment of T cells [47]. Based on the early
mortality observed in our model, it seems unlikely that improper
recruitment of T cells is responsible for this increased susceptibility
to CB4 infection. Rather, we hypothesize that CCL5 deficiency
results in a decrease recruitment of macrophages that may be
important for the production of TNF-a and, potentially, nitric
oxide. To this effect, we observed that the adoptive transfer of a
population composed mostly of macrophages but not DCs from
WT mice was sufficient to reduce mortality induced by CB4 in
TLR3KO mice by preventing viral-mediated cardiac pathology.
These data suggest that TLR3 signaling on macrophages results in
the production of TNF-a and CCL5 both of which act to control
early viral replication which, in turn, likely allows for the adaptive
immune response to activate and clear the viral infection.
Contrary to what has been reported for several other viruses
including another picornavirus [22,23], TLR3 signaling plays a
role in the protection of the host from cardiotropic viruses such as
coxsackievirus and EMCV[17]. Susceptibility to viral-induced
myocarditis is dependent on several genetic traits [48]. Our
observations suggest that genetic differences leading to changes in
TLR3 function or expression could be linked to susceptibility to
viral-induced myocarditis. To this effect, it was recently reported
that differences in susceptibility to chronic viral-induced myocar-
ditis between a C57Bl/6 and A.BY/SnJ mice was linked with
reduced production of TNF-a and CCL5 following coxsackievirus
B3 infection in a potentially TLR3-dependent manner [49].
Similarly, patients with a TLR3 deficiency are highly susceptible
to Herpes Simplex encephalitis [20]. Taken together, these
observations suggest that therapies aimed at re-establishing
TLR3 signaling or its functional consequences may provide an
effective means to protect susceptible patients from suffering the
fatal consequences of viral myocarditis.
In summary, we provide evidence for an essential non-
redundant role for TLR3 signaling on macrophages in the early
stages of coxsackievirus B4 infection. Our results demonstrate that
the production of important pro-inflammatory mediators such as
TNF-a and CCL5 are dependent on the TLR3 signaling pathway
and independent of the MyD88 pathway. Further, we demonstrate
that mortality occurs despite the normal activation of the adaptive
immune response. This suggests that in the absence of macro-
phages recognizing the invading pathogen in a TLR3 dependent
manner, viral replication cannot be controlled and is allowed to
outpace the developing adaptive immune response. The differ-
ences in requirement for TLR3 signaling between RNA viruses
(eg. LCMV and CB4) suggest that the wide variety of viral-specific
pattern recognition receptors does not represent simple redun-
dancy. Rather this system has been evolved to provide a first-line
of defense tailored to the requirements of the host to protect itself
against a specific virus. As such, gaining understanding of this
complex interplay of viruses with the innate immune system will
likely provide insight for the design of more effective antiviral
therapeutics.
Materials and Methods
Mice
NOD/ShiLtJ and TLR3KO mice were obtained from The
Jackson Laboratory (Bar Harbor, USA). TLR3KO mice were
backcrossed and maintained on the NOD background.
MyD88KO mice on the NOD background were a generous gift
from Dr. A. Chervonsky (University of Chicago). All mice were
bred and maintained in our rodent facility and monitored for
blood glucose prior to infection to ensure that only pre-diabetic
mice were analyzed. All performed procedures followed the
guidelines of the institutional animal care committee.
Virus
Stocks of CB4 Edwards strain 2 was originally obtained from
Dr. C. Gauntt (University of Texas-San Antonio) and prepared as
described previously [50,51]. LCMV Armstrong strain 53b was
originally obtained from Dr. M.B. Oldstone and propagated as
described previously [52]. 6–8 week old mice were infected
intraperitoneally with sublethal doses of 400 PFU of CB4 or
1610
5 PFU of LCMV. Viral titers were measured following
standard plaque assay procedures.
Flow cytometry
Single cell suspensions were generated from the spleen at the
indicated time points, stained for the appropriate markers and
analyzed by flow cytometry. Fluorescently conjugated antibodies
directed against CD11b (clone M1/70), CD11c (clone HL3), CD4
(clone L3T4), CD8 (clone 53-6.7), CD19 (clone eBio 1D3), panNK
(clone DX5) and CD69 (clone H1.2F3) were purchased from
eBiosciences (San Diego, USA) while biotin conjugated antibodies
directed against CD44 (clone IM7), CD62L (clone Mel-14), CD69
(clone H1.2F3), CD80 (clone 16-10A1) and, CD86 (clone GL1)
were purchased from BD Biosciences (Missisauga, Canada).
Immunohistochemical staining
Tissue sections were prepared as previously described [51] at
day 7 PI. Staining was performed using standard procedures for
hematoxylin and eosin (Wax-It, Vancouver, British Columbia).
Tissue sections were graded for pathology.
Quantitative measurement of liver damage
Liver damage was quantified at days 3 and 7 PI by measuring
serum levels of alanine transaminase (ALT) using commercially
available Infinity
TM ALT reagents (Thermo Scientific, Waltham,
MA) according to manufacturer’s instructions.
Quantitative measurement of heart damage
Heart damage was quantified by measuring release of cardiac
troponin 1 into the serum of mock-infected or infected mice at
days 3 and 7 PI using a commercially available ELISA kit (Life
Diagnostics, West Chester, PA) according to manufacturer’s
instruction.
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Serum cytokine and chemokine levels were measured at day 4
PI using a mouse inflammation CBA kit (BD Bioscience) allowing
for simultaneous detection IL-6, IL-10, MCP-1, IFN-c, TNF-a
and IL-12p70 from a single sample or a chemokine flex set (BD
Bioscience) customized to allow for simultaneous detection of
CXCL9 (MIG), CCL3 (MIP1a), CCL4 (MIP1b) and CCL5
(RANTES) from a single sample. Samples were prepared
according to manufacturer’s instructions and analyzed on a
BDFacsArray equipped with FCAP software (BDBiosciences).
Serum levels of IFNa were measured at 48 hours PI using a
VeriKine
TM Mouse interferon alpha kit (PBL interferon source,
Piscataway, NJ) according to manufacturer’s instructions.
Adoptive transfer experiments
Splenic single cell suspension from uninfected WT NOD or
TLR3KO mice were stained with fluorescently conjugated
antibodies specific for CD11b and CD11c. Cells were sorted by
FACS into two separate populations composed mainly of
macrophages (CD11b
+CD11c2) or mainly dendritic cells
(CD11c
+ with varying expression of CD11b). TLR3KO mice
were adoptively transferred with 2610
5 and a number of DCs
corresponding to the natural ratio of these cells compared to the
CD11b
+CD11c2 group (between 70,000 to 150,000) intraperito-
neally and challenged with CB4 24 hours post-transfer.
Statistical Analysis
Kaplan-Meier analysis was used to compare survival curves and
unpaired Student’s t-test was used for all other analyses. A P value
of ,0.05 was considered significant.
Supporting Information
Figure S1 MyD88 deficiency decreases the capacity of cellular
effectors to activate in response to CB4 infection. Representative
histograms of expression of activation or costimulatory marker (as
indicated) on the surface of A) NK cells (Pan-NK+, TCRb 2), B)
NK T cells (Pan-NK+, TCRb +), C) macrophages
(CD11b+CD11c2), D) dendritic cells (CD11c+), E) B cells
(CD19+), F) CD4+ T cells and G) CD8+ T cells from MyD88KO
mice at day 4 post-infection with 400 pfu of CB4 (solid black lines)
or mock-infection with DMEM (shaded histogram). Data is
representative of at least 2 separate experiments.
Found at: doi:10.1371/journal.pone.0004127.s001 (0.70 MB TIF)
Figure S2 TLR3 deficiency does not affect the capacity of APCs
to mature following LCMV infection. Representative histograms
of CD80 and CD86 expression on the surface of (A) macrophages
(CD11b+CD11c2) and (B) dendritic cells (CD11c+) from WT
NOD (left panels) and TLR3KO (right panels) mice at 4 days post-
infection with 16105 pfu of LCMV (solid black lines) or mock-
infection with DMEM (shaded histogram). Data is representative
of at least 2 separate experiments.
Found at: doi:10.1371/journal.pone.0004127.s002 (0.59 MB TIF)
Figure S3 TLR3 deficiency does not affect the capacity of B cells
to activate following CB4 infection. Representative histograms of
CD69 and CD86 expression on the surface of B cells (CD19+)
from WT NOD (left panels) and TLR3KO (right panels) mice at 4
days post-infection with 400 pfu of CB4 (solid black lines) or mock-
infection with DMEM (shaded histogram). Data is representative
of at least 2 separate experiments.
Found at: doi:10.1371/journal.pone.0004127.s003 (0.33 MB TIF)
Figure S4 TLR3 deficiency does not affect the capacity of T
cells to activate following LCMV infection. Representative
histograms of CD62L and CD69 expression on the surface of
(A) CD4 and (B) CD8 T cells from WT NOD (left panels) and
TLR3KO (right panels) mice at 4 days post-infection with
16105 pfu of LCMV (solid black lines) or mock-infection with
DMEM (shaded histogram). Data is representative of at least 2
separate experiments.
Found at: doi:10.1371/journal.pone.0004127.s004 (0.61 MB TIF)
Figure S5 TLR3 deficiency does not affect T cell activation
following LCMV or CB4 infection. Representative histograms of
CD44 expression on the surface of (A, C) CD4 and (B, D) CD8 T
cells from WT NOD (left panels) and TLR3KO (right panels) mice
at 7 days post-infection with (A,B) 400 pfu of CB4 (solid black
lines) or (C,D) 16105 pfu of LCMV (solid black lines) or mock-
infection with DMEM (shaded histogram). Data is representative
of at least 2 separate experiments.
Found at: doi:10.1371/journal.pone.0004127.s005 (0.61 MB TIF)
Figure S6 Type 1 interferon production is reduced following
CB4 infection in both TLR3KO and MyD88KO mice. Serum
levels of IFNa from WT NOD (black bars), TLR3KO (white bars)
and MyD88KO (grey bars) mice were measured with a VeriKine
Elisa Kit at 48 hours following infection with 400 pfu of N= at
least 7 for each group. Pooled data from at least 2 independent
experiments are presented as mean+/2s.e.m.
Found at: doi:10.1371/journal.pone.0004127.s006 (0.20 MB TIF)
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